Do prefrontal midline electrodes provide unique neurophysiologic information in Major Depressive Disorder?

Journal of Psychiatric Research

Volumn 53, Issue 1, 2014, Pages 69-75

  Cook, Ian A ^a,b   Hunter, Aimee M ^a   Korb, Alexander S ^a   Leuchter, Andrew F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

Author keywords

Clinical monitoring; Depression; EEG; Neurophysiology; Prefrontal cortex

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ADULT DISEASE; ARTICLE; BIOINFORMATICS; CLINICAL EXAMINATION; CONTROLLED STUDY; ELECTROENCEPHALOGRAPH ELECTRODE; EYE MOVEMENT; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NEUROPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; STRUCTURED INTERVIEW; ANALYSIS OF VARIANCE; BRAIN MAPPING; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; SPECTROSCOPY;

ADULT; ANALYSIS OF VARIANCE; BRAIN MAPPING; BRAIN WAVES; DEPRESSIVE DISORDER, MAJOR; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; SPECTRUM ANALYSIS;

EID: 84897412009     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2014.01.018     Document Type: Article

References (91)

1. Ahs F., Sollers J.J., Furmark T., Fredrikson M., Thayer J.F. High-frequency heart rate variability and cortico-striatal activity in men and women with social phobia. NeuroImage 2009, 47:815-820.
2. Allen J.J., Kline J.P. Frontal EEG asymmetry, emotion, and psychopathology: the first, and the next 25 years. Biol Psychol 2004, 67:1-5.
3. Asada H., Fukuda Y., Tsunoda S., Yamaguchi M., Tonoike M. Frontal midline theta rhythms reflect alternative activation of prefrontal cortex and anterior cingulate cortex in humans. Neurosci Lett 1999, 274:29-32.
4. Assal F., Cummings J.L. Neuropsychiatric symptoms in the dementias. Curr Opin Neurol 2002, 15:445-450.
5. Bagby R.M., Ryder A.G., Schuller D.R., Marshall M.B. The Hamilton Depression Rating Scale: has the gold standard become a lead weight?. Am J Psychiatry 2004, 161:2163-2177.
6. Baiano M., David A., Versace A., Churchill R., Balestrieri M., Brambilla P. Anterior cingulate volumes in schizophrenia: a systematic review and a meta-analysis of MRI studies. Schizophr Res 2007, 93:1-12.
7. Bares M., Brunovsky M., Kopecek M., Novak T., Stopkova P., Kozeny J., et al. Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder. Eur Psychiatry 2008, 23:350-355.
8. Bares M., Brunovsky M., Kopecek M., Stopkova P., Novak T., Kozeny J., et al. Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study. JPsychiatric Res 2007, 41:319-325.
9. Bench C.J., Friston K.J., Brown R.G., Scott L.C., Frackowiak R.S., Dolan R.J. The anatomy of melancholia - focal abnormalities of cerebral blood flow in major depression. Psychol Med 1992, 22:607-615.
10. Bocker K.B., van Avermaete J.A., van den Berg-Lenssen M.M. The international 10-20 system revisited: cartesian and spherical co-ordinates. Brain Topogr 1994, 6:231-235.
11. Broadway J.M., Holtzheimer P.E., Hilimire M.R., Parks N.A., Devylder J.E., Mayberg H.S., et al. Frontal theta cordance predicts 6-month antidepressant response to subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot study. Neuropsychopharmacology 2012, 37:1764-1772. 10.1038/npp.2012.23.
12. Brody A.L., Saxena S., Stoessel P., Gillies L.A., Fairbanks L.A., Alborzian S., et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry 2001, 58:631-640.
13. Bruder G.E., Fong R., Tenke C.E., Leite P., Towey J.P., Stewart J.E., et al. Regional brain asymmetries in major depression with or without an anxiety disorder: a quantitative electroencephalographic study. Biol Psychiatry 1997, 41:939-948.
14. Buchsbaum M.S., Wu J., Siegel B.V., Hackett E., Trenary M., Abel L., et al. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry 1997, 41:15-22.
15. Chatrian G.E., Lettich E., Nelson P.L. Modified nomenclature for the "10%" electrode system. JClin Neurophysiol 1998, 5:183-186.
16. Cook I.A., Hunter A.M., Abrams M., Siegman B., Leuchter A.F. Midline and right frontal brain function as a physiologic biomarker of remission in major depression. Psychiatry Res 2009, 174:152-157.
17. Cook I.A., Hunter A.M., Gilmer W.S., Iosifescu D.V., Zisook S., Burgoyne K.S., et al. Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial. JClin Psychiatry 2013, 74:51-56.
18. Cook I.A., Leuchter A.F. Prefrontal changes and treatment response prediction in depression. Semin Clin Neuropsychiatry 2001, 6:113-120.
19. Cook I.A., Leuchter A.F., Morgan M.L., Stubbeman W., Siegman B., Abrams M. Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. JPsychiatric Res 2005, 39:461-466.
20. Cook I.A., Leuchter A.F., Morgan M., Witte E., Stubbeman W.F., Abrams M., et al. Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology 2002, 27:120-131.
21. Cook I.A., Leuchter A.F., Uijtdehaage S.H., Osato S., Holschneider D.H., Abrams M., et al. Altered cerebral energy utilization in late life depression. JAffect Disord 1998, 49:89-99.
22. Cook I.A., O'Hara R., Uijtdehaage S.H., Mandelkern M., Leuchter A.F. Assessing the accuracy of topographic EEG mapping for determining local brain function. Electroencephalogr Clin Neurophysiol 1998, 107:408-414.
23. Davidson R.J. What does the prefrontal cortex "do" in affect: perspectives on frontal EEG asymmetry research. Biol Psychol 2004, 67:219-233.
24. Davidson R.J., Irwin W. The functional neuroanatomy of emotion and affective style. Trends Cogn Sci 1999, 3:11-21.
25. Delmonte S., Gallagher L., O'Hanlon E., McGrath J., Balsters J.H. Functional and structural connectivity of frontostriatal circuitry in Autism Spectrum Disorder. Front Hum Neurosci 2013, 7:430.
26. Drevets W.C., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., Raichle M.E. Afunctional anatomical study of unipolar depression. JNeurosci 1992, 12:3628-3641.
27. Erdfelder E., Faul F., Buchner A. GPower: a general power analysis program. Behav Res Methods Instrum Comput 1996, 28:1-11.
28. Fitzgerald P.B., Laird A.R., Maller J., Daskalakis Z.J. Ameta-analytic study of changes in brain activation in depression. Hum Brain Mapp 2008, 29:683-695.
29. Fountoulakis K.N., Giannakopoulos P., Kovari E., Bouras C. Assessing the role of cingulate cortex in bipolar disorder: neuropathological, structural and functional imaging data. Brain Res Rev 2008, 59:9-21.
30. Gevins A., Smith M.E., McEvoy L., Yu D. High-resolution EEG mapping of cortical activation related to working memory: effects of task difficulty, type of processing, and practice. Cereb Cortex 1997, 7:374-385.
31. Gibbons R.D., Clark D.C., Kupfer D.J. Exactly what does the Hamilton depression rating scale measure?. JPsychiatric Res 1993, 27:259-273.
32. Hall S.S., Jiang H., Reiss A.L., Greicius M.D. Identifying large-scale brain networks in fragile X syndrome. JAMA Psychiatry 2013, 70:1215-1223. 10.1001/jamapsychiatry.2013.247.
33. Hamilton M. Arating scale for depression. JNeurol Neurosurg Psychiatr 1960, 23:56-62.
34. Hjorth B. An on-line transformation of EEG scalp potentials into orthogonal source derivations. Electroencephalogr Clin Neurophysiol 1975, 39:526-530.
35. Holmes A.J., Pizzagalli D.A. Spatiotemporal dynamics of error processing dysfunctions in major depressive disorder. Arch Gen Psychiatry 2008, 65:179-188.
36. Hunter A.M., Cook I.A., Leuchter A.F. Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of major depression. JClin Psychopharmacol 2010, 30:748-751.
37. Hunter A.M., Cook I.A., Leuchter A.F. Does prior antidepressant treatment of major depression impact brain function during current treatment?. Eur Neuropsychopharmacol 2012, 22:711-720. 10.1016/j.euroneuro.2012.02.005.
38. Hunter A.M., Korb A.S., Cook I.A., Leuchter A.F. Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication?. JNeuropsychiatry Clin Neurosci 2013, 25:126-133.
39. Hunter A.M., Leuchter A.F., Morgan M.L., Cook I.A. Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. Am J Psychiatry 2006, 163:1426-1432.
40. Iramina K., Ueno S., Matsuoka S. MEG and EEG topography of frontal midline theta rhythm and source localization. Brain Topogr 1996, 8:329-331.
41. Ishii R., Shinosaki K., Ukai S., Inouye T., Ishihara T., Yoshimine T., et al. Medial prefrontal cortex generates frontal midline theta rhythm. NeuroReport 1999, 10:675-679.
42. Ito H., Kawashima R., Awata S., Ono S., Sato K., Goto R., et al. Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique. JNucl Med 1996, 37:410-414.
43. Jasper H. The 10-20 electrode system of the international federation. Electroencephalogr Clin Neurophysiol 1958, 10:371-375.
44. Juckel G., Pogarell O., Augustin H., Mulert C., Müller-Siecheneder F., Frodl T., et al. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. JClin Psychiatry 2007, 68:1206-1212.
45. Jurcak V., Tsuzuki D., Dan I. 10/20, 10/10, and 10/5 systems revisited: their validity as relative head-surface-based positioning systems. NeuroImage 2007, 34:1600-1611.
46. Kennedy S.H., Evans K.R., Krüger S., Mayberg H.S., Meyer J.H., McCann S., et al. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 2001, 158:899-905.
47. Kimbrell T.A., Ketter T.A., George M.S., Little J.T., Benson B.E., Willis M.W., et al. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry 2002, 51:237-252.
48. Knott V.J., Telner J.I., Lapierre Y.D., Browne M., Horn E.R. Quantitative EEG in the prediction of antidepressant response to imipramine. JAffect Disord 1996, 39:175-184.
49. Korb A.S., Cook I.A., Hunter A.M., Leuchter A.F. Brain electrical source differences between depressed subjects and healthy controls. Brain Topogr 2008, 21:138-146.
50. Korb A.S., Hunter A.M., Cook I.A., Leuchter A.F. Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression. Clin Neurophysiol 2009, 120:1313-1319.
51. Korb A.S., Hunter A.M., Cook I.A., Leuchter A.F. Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder. Psychiatry Res 2011, 192:188-194.
52. Leuchter A.F., Cook I.A., DeBrota D.J., Hunter A.M., Potter W.Z., McGrouther C.C., et al. Changes in brain function during administration of venlafaxine or placebo to normal subjects. Clin EEG Neurosci 2008, 39:175-181.
53. Leuchter A.F., Cook I.A., Gilmer W.S., Burgoyne K.S., Howland R.H., Trivedi M.H., et al. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Res 2009, 169:132-138.
54. Leuchter A.F., Cook I.A., Hunter A.M., Cai C., Horvath S. Resting-state quantitative electroencephalography reveals increased neurophysiologic connectivity in depression. PLoS One 2012, 7:e32508.
55. Leuchter A.F., Cook I.A., Marangell L.B., Gilmer W.S., Burgoyne K.S., Howland R.H., et al. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Res 2009, 169(2):124-131.
56. Leuchter A.F., Cook I.A., Uijtdehaage S.H., Dunkin J., Lufkin R.B., Anderson Hanley C., et al. Brain structure and function and the outcomes of treatment for depression. J Clin Psychiatry 1997, 58(Suppl. 16):22-31.
57. Leuchter A.F., Cook I.A., Witte E.A., Morgan M., Abrams M. Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry 2002, 159:122-129.
58. Leuchter A.F., Uijtdehaage S.H., Cook I.A., O'Hara R., Mandelkern M. Relationship between brain electrical activity and cortical perfusion in normal subjects. Psychiatry Res 1999, 90:125-140.
59. Mayberg H.S., Brannan S.K., Mahurin R.K., Jerabek P.A., Brickman J.S., Tekell J.L., et al. Cingulate function in depression: a potential predictor of treatment response. NeuroReport 1997, 8:1057-1061.
60. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999, 156:675-682.
61. McCormick L.M., Yamada T., Yeh M., Brumm M.C., Thatcher R.W. Antipsychotic effect of electroconvulsive therapy is related to normalization of subgenual cingulate theta activity in psychotic depression. JPsychiatric Res 2009, 43:553-560.
62. Minzenberg M.J., Fan J., New A.S., Tang C.Y., Siever L.J. Frontolimbic structural changes in borderline personality disorder. JPsychiatric Res 2008, 42:727-733.
63. Mulert C., Juckel G., Augustin H., Hegerl U. Comparison between the analysis of the loudness dependency of the auditory N1/P2 component with LORETA and dipole source analysis in the prediction of treatment response to the selective serotonin reuptake inhibitor citalopram in major depression. Clin Neurophysiol 2002, 113:1566-1572.
64. Mulert C., Juckel G., Brunnmeier M., Karch S., Leicht G., Mergl R., et al. Rostral anterior cingulate cortex activity in the theta band predicts response to antidepressive medication. Clin EEG Neurosci 2007, 38:78-81.
65. Mulert C., Juckel G., Brunnmeier M., Karch S., Leicht G., Mergl R., et al. Prediction of treatment response in major depression: integration of concepts. JAffect Disord 2007, 98:215-225.
66. Narushima K., McCormick L.M., Yamada T., Thatcher R.W., Robinson R.G. Subgenual cingulate theta activity predicts treatment response of repetitive transcranial magnetic stimulation in participants with vascular depression. JNeuropsychiatry Clin Neurosci 2010, 22:75-84.
67. Nuwer M.R. Recording electrode site nomenclature. JClin Neurophysiol 1987, 4:121-133.
68. Pascual-Marqui R.D., Michel C.M., Lehmann D. Low resolution electromagnetic tomography: a new method for localizing electrical activity in the brain. Int J Psychophysiol 1994, 18:49-65.
69. Peyron R., Laurent B., García-Larrea L. Functional imaging of brain responses to pain. A review and meta-analysis. Neurophysiol Clin 2000, 30:263-288.
70. Pizzagalli D.A., Oakes T.R., Davidson R.J. Coupling of theta activity and glucose metabolism in the human rostral anterior cingulate cortex: an EEG/PET study of normal and depressed subjects. Psychophysiology 2003, 40:939-949.
71. Pizzagalli D., Pascual-Marqui R.D., Nitschke J.B., Oakes T.R., Larson C.L., Abercrombie H.C., et al. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry 2001, 158:405-415.
72. Plante D.T., Landsness E.C., Peterson M.J., Goldstein M.R., Wanger T., Guokas J.J., et al. Altered slow wave activity in major depressive disorder with hypersomnia: a high density EEG pilot study. Psychiatry Res 2012, 201:240-244.
73. Porter R.J., Bourke C., Gallagher P. Neuropsychological impairment in major depression: its nature, origin and clinical significance. Aust N Z J Psychiatry 2007, 41:115-128.
74. Posner M.I., Rothbart M.K., Sheese B.E., Tang Y. The anterior cingulate gyrus and the mechanism of self-regulation. Cogn Affect Behav Neurosci 2007, 7:391-395.
75. Poulsen C., Luu P., Crane S.M., Quiring J., Tucker D.M. Frontolimbic activity and cognitive bias in major depression. JAbnorm Psychol 2009, 118:494-506.
76. Rauch S.L., Savage C.R., Alpert N.M., Miguel E.C., Baer L., Breiter H.C., et al. Apositron emission tomographic study of simple phobic symptom provocation. Arch Gen Psychiatry 1995, 52:20-28.
77. Rigucci S., Serafini G., Pompili M., Kotzalidis G.D., Tatarelli R. Anatomical and functional correlates in major depressive disorder: the contribution of neuroimaging studies. World J Biol Psychiatry 2010, 11(2 Pt 2):165-180.
78. Saletu B., Anderer P., Saletu-Zyhlarz G.M. EEG topography and tomography (LORETA) in diagnosis and pharmacotherapy of depression. Clin EEG Neurosci 2010, 41:203-210.
79. Sauseng P., Hoppe J., Klimesch W., Gerloff C., Hummel F.C. Dissociation of sustained attention from central executive functions: local activity and interregional connectivity in the theta range. Eur J Neurosci 2007, 25:587-593.
80. Schrijvers D., De Bruijn E.R., Maas Y., De Grave C., Sabbe B.G., Hulstijn W. Action monitoring in major depressive disorder with psychomotor retardation. Cortex 2008, 44:569-579.
81. Schrijvers D., De Bruijn E.R., Maas Y.J., Vancoillie P., Hulstijn W., Sabbe B.G. Action monitoring and depressive symptom reduction in major depressive disorder. Int J Psychophysiol 2009, 71(3):218-224.
82. Sharbrough F.W., Chatrian G.E., Lesser R., Luders H., Nuwer M.R., Picton T.W. American Electroencephalographic Society guidelines for standard electrode position nomenclature. JClin Neurophysiol 1991, 8:200-202.
83. Sheline Y.I., Price J.L., Yan Z., Mintun M.A. Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus. Proc Natl Acad Sci U S A 2010, 107:11020-11025.
84. Trivedi M.H., Corey-Lisle P.K., Guo Z., Lennox R.D., Pikalov A., Kim E. Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning. Int Clin Psychopharmacol 2009, 24:133-138.
85. Tsujimoto T., Shimazu H., Isomura Y. Direct recording of theta oscillations in primate prefrontal and anterior cingulate cortices. JNeurophysiol 2006, 95:2987-3000.
86. Ulrich G., Haug H.J., Stieglitz R.D., Fähndrich E. EEG characteristics of clinically defined on-drug-responders and non-responders-a comparison clomipramine vs. maprotiline. Pharmacopsychiatry 1988, 21:367-368.
87. Ulrich G., Haug H.J., Stieglitz R.D., Fähndrich E. Are there distinct biochemical subtypes of depression? EEG characteristics of clinically defined on-drug responders and non-responders. J Affect Disord 1988, 15:181-185.
88. Ulrich G., Haug H.J., Fähndrich E. Acute vs. chronic EEG effects in maprotiline- and in clomipramine-treated depressive inpatients and the prediction of therapeutic outcome. J Affect Disord 1994, 32:213-217.
89. van Veen V., Carter C.S. The anterior cingulate as a conflict monitor: fMRI and ERP studies. Physiol Behav 2002, 77:477-482.
90. van Veen V., Carter C.S. Error detection, correction, and prevention in the brain: a brief review of data and theories. Clin EEG Neurosci 2006, 37:330-335.
91. Zakzanis K.K., Leach L., Kaplan E. On the nature and pattern of neurocognitive function in major depressive disorder. Neuropsychiatry Neuropsychol Behav Neurol 1998, 11:111-119.